Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04968847 · ClinicalTrials.gov registry record · NA
FemaSeed LOCAL Artificial Insemination Trial
A NA study, sponsored by Femasys.
- Completed
- Registry status
- NA
- Development phase
- 314
- Enrollment target
NCT04968847: Completed NA study, sponsored by Femasys.
NCT04968847 is a NA study that has completed, run by Femasys. The registered enrollment target is 314 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04968847, a NA study, has completed, sponsored by Femasys.
- COMPLETED
- Registry status
- NA
- Development phase
- 314 participants
- Enrollment target
Study Summary
Brief Summary: The objectives of the trial are to evaluate the safety and effectiveness of the FemaSeed Localized Directional Insemination for artificial insemination, now known as the FemaSeed Intratubal Insemination since FDA Cleared under K231730 in September 2023.
Primary Outcome
Confirmed pregnancy rate per cycle: defined as the proportion of cycles with one intrauterine insemination with FemaSeed that result in pregnancy.
Interventions
- DEVICE FemaSeed Localized Directional Insemination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
What the finished NCT04968847 record still lists
NCT04968847 is an interventional study that assigns participants to a tested intervention. The registered 314 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which FemaSeed Localized Directional Insemination is the first listed.
NCT04968847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04968847 about?
NCT04968847 is a clinical study titled "FemaSeed LOCAL Artificial Insemination Trial". Brief Summary: The objectives of the trial are to evaluate the safety and effectiveness of the FemaSeed Localized Directional Insemination for artificial insemination, now known as the FemaSeed Intratubal Insemination since FDA Cleared under K231730 in September 2023.
What is the current status of trial NCT04968847?
This trial is currently completed. It is a NA study. The enrollment target is 314 participants. The study started on 2021-07-15. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT04968847?
The interventions under investigation include: FemaSeed Localized Directional Insemination (DEVICE).
Who is sponsoring clinical trial NCT04968847?
This trial is sponsored by Femasys, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04968847's enrollment target sits among peer trials
314 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03866382 · 314 participants · Phase 2
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- NCT04500756 · 314 participants · Phase 2
Limiting AAA With Metformin (LIMIT) Trial
- NCT06167746 · 314 participants · Phase 3
iCare4Me Transitions
- NCT06883097 · 314 participants · NA
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI